SPC
AMGN icon

Spirepoint Private Client’s Amgen AMGN Stock Holding History

Spirepoint Private Client’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Sell
5,603
-279
-5% -$99.5K 0.19% 82
2025
Q4 		$1.93M Sell
5,882
-22
-0.4% -$6.98K 0.18% 79
2025
Q3 		$1.67M Buy
5,904
+471
+9% +$137K 0.18% 83
2025
Q2 		$1.52M Sell
5,433
-3
-0.1% -$850 0.17% 85
2025
Q1 		$1.69M Sell
5,436
-174
-3% -$51.4K 0.22% 70
2024
Q4 		$1.46M Buy
5,610
+1,569
+39% +$466K 0.18% 74
2024
Q3 		$1.3M Sell
4,041
-42
-1% -$13.7K 0.17% 82
2024
Q2 		$1.28M Buy
4,083
+180
+5% +$52.9K 0.18% 80
2024
Q1 		$1.11M Buy
+3,903
New +$1.14M 0.17% 84

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Spirepoint Private Client's AMGN Position: Q1 2026 in Review

Spirepoint Private Client reduced its Amgen (AMGN) stake by 4.7% in Q1 2026, selling an estimated $99.5K and leaving 5,603 shares worth $1.97M. The position accounts for 0.19% of the portfolio, ranked #82.

Spirepoint Private Client first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Spirepoint Private Client held 5,603 shares of Amgen worth $1.97M as of Q1 2026.
  • Spirepoint Private Client sold 279 Amgen shares in Q1 2026, an estimated $99.5K.
  • Amgen made up 0.19% of Spirepoint Private Client's portfolio in Q1 2026, its #82 holding.
  • Spirepoint Private Client first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.